113 related articles for article (PubMed ID: 16033375)
1. Comment on 'What is the direct cost of treatment of acute primary angle closure glaucoma? The Singapore model'.
Papalkar D; Francis IC; Lim R
Clin Exp Ophthalmol; 2005 Aug; 33(4):446; author reply 447. PubMed ID: 16033375
[No Abstract] [Full Text] [Related]
2. What is the direct cost of treatment of acute primary angle closure glaucoma? The Singapore model.
Wang JC; Chew PT
Clin Exp Ophthalmol; 2004 Dec; 32(6):578-83. PubMed ID: 15575827
[TBL] [Abstract][Full Text] [Related]
3. Economic considerations of the diagnosis and management for glaucoma in the developed world.
Tuulonen A
Curr Opin Ophthalmol; 2011 Mar; 22(2):102-9. PubMed ID: 21192264
[TBL] [Abstract][Full Text] [Related]
4. Glaucoma care cost-effectiveness.
Hoskins HD
Ophthalmology; 2009 May; 116(5):1016. PubMed ID: 19410965
[No Abstract] [Full Text] [Related]
5. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
[TBL] [Abstract][Full Text] [Related]
6. Glaucoma in the United States and europe: predicting costs and surgical rates based upon stage of disease.
Lee PP; Kelly SP; Mills RP; Traverso CE; Walt JG; Doyle JJ; Katz LM; Siegartel LR;
J Glaucoma; 2007 Aug; 16(5):471-8. PubMed ID: 17700290
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness: insights on treatment options for open-angle glaucoma.
Morse AR; Lee PP
Arch Ophthalmol; 2012 Apr; 130(4):506-7. PubMed ID: 22491919
[No Abstract] [Full Text] [Related]
8. Acute primary angle closure-treatment strategies, evidences and economical considerations.
Chan PP; Pang JC; Tham CC
Eye (Lond); 2019 Jan; 33(1):110-119. PubMed ID: 30467424
[TBL] [Abstract][Full Text] [Related]
9. Considerations in developing model-based economic evaluations of glaucoma treatment.
Althin R; Grima DT; Dhawan R; Bernard LM
J Glaucoma; 2006 Dec; 15(6):541-7. PubMed ID: 17106369
[TBL] [Abstract][Full Text] [Related]
10. The cost of glaucoma care provided to Medicare beneficiaries from 2002 to 2009.
Quigley HA; Cassard SD; Gower EW; Ramulu PY; Jampel HD; Friedman DS
Ophthalmology; 2013 Nov; 120(11):2249-57. PubMed ID: 23769330
[TBL] [Abstract][Full Text] [Related]
11. Shared Cared for Stable Glaucoma Patients: Economic Benefits and Patient-centered Outcomes of a Feasibility Trial.
Goh D; de Korne DF; Ho H; Mathur R; Chakraborty B; Van Hai N; Wai C; Perera S; Aung T; Wong TY; Lamoureux EL
J Glaucoma; 2018 Feb; 27(2):170-175. PubMed ID: 29271805
[TBL] [Abstract][Full Text] [Related]
12. Glaucoma: where to now?
Taylor HR
Ophthalmology; 2009 May; 116(5):821-2. PubMed ID: 19410940
[No Abstract] [Full Text] [Related]
13. Economic impact of primary open-angle glaucoma in Australia.
Dirani M; Crowston JG; Taylor PS; Moore PT; Rogers S; Pezzullo ML; Keeffe JE; Taylor HR
Clin Exp Ophthalmol; 2011; 39(7):623-32. PubMed ID: 21631669
[TBL] [Abstract][Full Text] [Related]
14. Current management options in primary angle closure disease.
Krishnadas R
Indian J Ophthalmol; 2019 Mar; 67(3):321-323. PubMed ID: 30777944
[No Abstract] [Full Text] [Related]
15. Costs of a community-based glaucoma detection programme: analysis of the Philadelphia Glaucoma Detection and Treatment Project.
Pizzi LT; Waisbourd M; Hark L; Sembhi H; Lee P; Crews JE; Saaddine JB; Steele D; Katz LJ
Br J Ophthalmol; 2018 Feb; 102(2):225-232. PubMed ID: 28655730
[TBL] [Abstract][Full Text] [Related]
16. Medical Costs of and Changes in Glaucoma Treatment among Patients Newly Starting Glaucoma Care.
Fukuda Y; Kume A; Kashiwagi K
Curr Eye Res; 2021 Nov; 46(11):1695-1702. PubMed ID: 33843390
[No Abstract] [Full Text] [Related]
17. Outcomes of combined lens extraction and goniosynechialysis in angle closure.
White AJ; Orros JM; Healey PR
Clin Exp Ophthalmol; 2013 Nov; 41(8):746-52. PubMed ID: 23601286
[TBL] [Abstract][Full Text] [Related]
18. Glaucoma Control Strategies in Sub-Saharan Africa: A Review of the Clinical and Health Economic Evidence.
Smith AF; Negretti G; Mascaro A; Bokre D; Baker H; Dhalla K; Murdoch IE
Ophthalmic Epidemiol; 2018; 25(5-6):419-435. PubMed ID: 30059637
[TBL] [Abstract][Full Text] [Related]
19. Cost-offset analysis: bimatoprost versus other prostaglandin analogues in open-angle glaucoma.
Berenson KL; Kymes S; Hollander DA; Fiscella R; Burk C; Patel VD
Am J Manag Care; 2011 Sep; 17(9):e365-74. PubMed ID: 21902444
[TBL] [Abstract][Full Text] [Related]
20. Incidence of acute angle-closure glaucoma in Dalmatia, southern Croatia.
Bojić L; Mandić Z; Ivanisević M; Bucan K; Kovacević S; Gverović A; Miletić-Jurić A
Croat Med J; 2004 Jun; 45(3):279-82. PubMed ID: 15185417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]